A new AI-driven technology for predicting breast cancer risk has received “Breakthrough Device” status from the FDA. This software, called Prognosia Breast, was developed by researchers at Washington University School of Medicine in St. Louis and licensed to the spin-off Prognosia Inc. The system is designed to accurately predict women’s individual five-year risk of developing […]
